CompletedNCT00616889
Quetiapine use and sleep in bipolar depression
About this title
Effect of Quetiapine on Sleep Architecture in Bipolar Depression and Major Depressive Disorder
Read the official source — NCT00616889Observational studyAges 18–65Canada
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- KingstonSee all locations and recruitment
Study information
Study start dateMay 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 15
- Sponsor
- Queen's University
- Sponsor type
- University
- Study type
- Observational
- Intervention type
- Drug
- Locations
- Canada
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00616889
- Official title
Show the full official title
Effects of Seroquel on Sleep Architecture in Patients With Bipolar Depression or Major Depressive Disorder - An Open Label Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Kingston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Queen's University, a university.
Did this study involve medication?
Yes. The study involved medication, including Seroquel.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
